Biovica has signed its second direct commercial client bill agreement with a larger healthcare provider operating 18 hospital laboratories, in Missouri. This is positive as it opens up for commercial and clinical DiviTum sales towards the end of this calendar year. This agreement is also based on a similar premium price as the earlier direct contract in Arizona and the earlier US provider network contracts introducing DiviTum to the private insurance segment. Biovica has an ambition to secure up to ten of these direct contracts by the end of April 2024.
LÄS MER
